Angioplasty
Renal artery stenting falls short in large randomized trial
Published in Law and Health Weekly, April 19th, 2008
CHICAGO, Ill. (April 1, 2008) — The largest-ever randomized study to evaluate the effectiveness of catheter-based interventions in patients with narrowing of the renal artery has shown that angioplasty and stenting offer no benefit over medical therapy. Among patients who completed one year of follow-up, there were no differences in the change in kidney function, blood pressure control or the rates of major cardiovascular illness, according to the Angioplasty and Stenting for Renal Artery Lesions (ASTRAL) trial.
The ASTRAL trial is being reported in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Aggression
Findings in aggression reported from University of Montreal - Alexza Pharmaceuticals, Inc.
Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. - Alzheimer Disease
Studies from University of Alabama, Alzheimer's Disease Research Center reveal new findings on Alzheimer disease - Ambulatory Surgery
Investigators at University of Toronto publish new data on ambulatory surgery - American Life League
American Life League: Planned Parenthood Scandals 'Widespread' - Anxiety Disorders
New research on anxiety disorders from University of Cape Town summarized - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
